Cell Therapeutics hopes to get FDA approval for pixantrone, European Opaxio in ’09
SEATTLE Cell Therapeutics announced several goals for 2009 at the JP Morgan Healthcare Conference in San Francisco earlier this week.
The Seattle-based biotech, which specializes in cancer drugs, is hoping to get Food and Drug Administration approval for the compound pixantrone, based on results of a phase 3 extended trial announced in November; the company plans to submit an approval application for the drug during fourth quarter 2009. It also hopes to get approval in Europe for Opaxio, a first-line treatment for patients with non-small cell lung cancer, through a possible commercialization agreement with Novartis.
It expects the FDA to decide in April whether to approve a supplemental application for Zevalin as a treatment for follicular non-Hodgkin’s lymphoma.
“With a focus on cutting-edge oncology drug products, CTI aims to complete its transition from a research-based organization to a leading commercial oncology company,” CEO James Bianco said in a statement.
MTI launches Rite Aid Radio
MIAMI BEACH, Fla. Music Technologies International on Tuesday announced that it’s “Rite Aid Radio,” a music and messaging program designed exclusively for Rite Aid, is now available chainwide.
“We relished the opportunity to start from scratch with Rite Aid in creating a music environment that is much more ‘tune’ with their customers,” said Bradley Golden, president of MTI. “We feel that we have helped to create an even more inviting audio ambiance in the stores.”
MTI built the music library song by song to appeal to Rite Aid’s customers, the company stated, and also allows Rite Aid to broadcast messages to speak directly to its customers.
This partnership is actually the resumption of a relationship from the 1990’s when MTI provided a similar program to Rite Aid.
“Our number one priority is keeping our customers happy,” said Jerry Cardinale, Rite Aid senior vice president of indirect procurement. “We feel that MTI’s music and messaging program helps us achieve this goal. MTI shares our philosophy of absolute dedication to customer service.”
Duane Reade announces $3.5 million settlement for Q4 2008
NEW YORK Duane Reade, without admitting liability, has announced a $3.5 million litigation settlement that will result in a $3.5 million one-time, pre-tax charge for the fourth quarter.
The two class action cases concern the retailer’s alleged past payment practices for certain overtime and employee non-exempt classifications.
The settlement is subject to the approval of the U.S. District Court for the Southern District of New York. The company stated that while it believes it can “strongly defend against the matters involved in this litigation” it has decided to settle to avoid additional defense costs and uncertainty surrounding the litigation.
The retailer, which operates 251 stores, is expected to announce its fourth quarter and fiscal year 2008 results in March.